{"id":"W2137319519","doi":"10.1124/jpet.111.183327","title":"Subchronic Administration and Combination Metabotropic Glutamate and GABAB Receptor Drug Therapy in Fragile X Syndrome","year":2011,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; University of California, Davis; National Institutes of Health","keywords":"Metabotropic glutamate receptor 5; Pharmacology; Metabotropic glutamate receptor; Metabotropic receptor; Metabotropic glutamate receptor 7; Glutamate receptor; Drug; Metabotropic glutamate receptor 4; Metabotropic glutamate receptor 1; Metabotropic glutamate receptor 2; Metabotropic glutamate receptor 3; Medicine; Chemistry; Receptor; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001102019,0.0001073886,0.0001277402,0.0000514102,0.0000502534,0.00001108909,0.00005368374,0.00006387912,0.00003873669],"category_scores_gemma":[0.000001018831,0.00009687464,0.00002173259,0.00003283684,0.0001083845,0.0000122969,0.0000344858,0.00009113814,4.23712e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001040981,"about_ca_system_score_gemma":0.00003725172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002323178,"about_ca_topic_score_gemma":0.000002046157,"domain_scores_codex":[0.9994293,0.00007487252,0.0002025636,0.0001255705,0.00005581456,0.000111903],"domain_scores_gemma":[0.9997838,0.000006689046,0.0001089244,0.00003323333,0.00002318337,0.00004418642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004752575,0.0002636536,0.003316812,0.000005774767,0.00007433136,0.000009542703,0.0005865367,8.55649e-7,0.9937628,0.00002948588,0.00006143159,0.001413501],"study_design_scores_gemma":[0.002913047,0.002425046,0.04656364,0.000005896232,0.00002252187,0.0001761535,0.0004046575,0.00003118093,0.945092,0.0001245949,0.002108881,0.0001323597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854583,0.0139561,0.000008266931,0.0001846668,0.000243398,0.0001069072,0.000001904975,0.000001656657,0.00003885308],"genre_scores_gemma":[0.9862363,0.01287941,0.0002715896,0.0005517249,0.00001380398,0.000005328738,0.000003540041,0.00001006935,0.00002827678],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04867079,"threshold_uncertainty_score":0.3950433,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02081922213262494,"score_gpt":0.2879103516579136,"score_spread":0.2670911295252887,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}